Hepatogastroenterology · 2011 · 686 citations · 0 references
MedicineMolecular BiologyOncologyEpigeneticsGastrointestinal OncologyMolecular OncologyCancer EpigeneticsDna Methylation ProfilingEpigenetic BiomarkersEpigenetic Regulation In CancerEsophageal CancerGastric CancerAberrant Dna MethylationCancer Epigenetic BiomarkersEpigenetics Of Gastric CancerLymph Node Metastasis PrognosisMethylation-specific AmplificationPathology Of Gastric CancerPromoter MethylationPromoter Methylation Analysis
BACKGROUND/AIMS: To detect the feasibility of using synchronous bile duct, left lobe of liver and common hepatic artery resection without reconstruction to improve the therapeutic efficacy of HC. METHODOLOGY: A total of 19 patients with hilar cholangiocarcinoma undergoing left-sided hepatectomy, hepatic artery resection and right hepatic duct-jejunum anastomosis from June 2005 to May 2010 in our team were included prospectively in this study. RESULTS: One case died from probable sudden myocardial infarction before discharge from hospital. Little bile leakage occurred in one case. No hepatic insufficiency developed in any cases. A follow-up of 6-66 months was applied and 11 cases were still alive at the end. CONCLUSIONS: Hepatic Arteriectomy is viable with lower total bilirubin and the excision weight up to about 30% of the standard liver.